Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

Success Metrics

Active Trials

2(100%)

Phase Distribution

Not Applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Detailed Status

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting2100%

Recent Activity

2 active trials

Showing 2 of 2

recruitingnot_applicable

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

NCT06851988

recruitingnot_applicable

Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients

NCT06666881

Clinical Trials (2)

Showing 2 of 2 trials

NCT06851988Not Applicable

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

Recruiting

NCT06666881Not Applicable

Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients

Recruiting

All 2 trials loaded

Drug Details

Intervention Type: Other
Total Trials: 2